Bioresorbable Polymers Companies

The bioresorbable polymers market is a dynamic and rapidly growing space, driven by advancements in medical technology and a rising demand for minimally invasive procedures. Tthis market is attracting significant attention from established players and emerging startups alike. Let's delve into the competitive landscape, exploring strategies, key factors for market share, industry news, and recent developments in the last six months.

Strategies Adopted by Players:

• Product Diversification: Leading players like Evonik, Corbion, and BASF are expanding their portfolios beyond traditional synthetic polymers, investing in natural polymers like hyaluronic acid and polylactic acid (PLA) to cater to growing sustainability concerns.


• Vertical Integration: Companies like Teijin and Resmed are strengthening their control over the supply chain by acquiring raw material suppliers and expanding manufacturing capabilities. This ensures stable supply and cost optimization.


• Technological Innovation: Research and development efforts are focused on developing new bioresorbable polymers with enhanced properties like faster degradation rates, improved biocompatibility, and targeted drug delivery capabilities.


• Regional Expansion: Established players are entering emerging markets like China and India, which offer significant growth potential due to their large populations and increasing healthcare spending.


• Partnerships and Collaborations: Strategic partnerships between polymer manufacturers, medical device companies, and research institutions are accelerating innovation and enabling faster product development cycles.

Factors Influencing Market Share:

• Product Portfolio: Companies with a diverse range of bioresorbable polymers catering to various applications hold a competitive advantage.


• Manufacturing Capacity and Efficiency: Scalable and cost-effective production capabilities are crucial for maintaining market share and profitability.


• Regulatory Approvals: Navigating complex regulatory requirements for medical devices can be a barrier for new entrants, giving established players an edge.


• Brand Recognition and Reputation: Strong brand recognition and a proven track record of safety and efficacy are crucial for attracting customers and healthcare professionals.


• Investment in Research and Development: Continuous innovation in new polymers and applications keeps companies ahead of the competition.

List of the Key Companies in the Bioresorbable Polymers market include

• Evonik Industries AG


• Corbion NV, Foster Corporation


• Poly-Med Inc.


• REVA Medical, Inc


• Groupe PCAS


• Merck KGaA


• Koninklijke DSM N.V


• KLS Martin


• Ashland

Recent Developments:

August 2023: A team of researchers from MIT unveils a bioresorbable polymer that can deliver drugs directly to diseased cells.

September 2023: The European Commission approves a new regulation on the use of bioresorbable polymers in medical devices, aimed at ensuring patient safety and product quality.

October 2023: A joint venture between a US and a Chinese company is formed to develop and commercialize bioresorbable polymers for bone regeneration applications.

November 2023: A major medical device conference features several presentations on the latest advancements in bioresorbable polymers for drug delivery and tissue engineering.